Savant Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.95M	Sell	53,653 -18,503	-26%	-$1.02M	0.02%	451
2025 Q1	$5.1M	Buy	72,156 +43,220	+149%	+$3.06M	0.04%	274
2024 Q4	$1.9M	Buy	28,936 +14,930	+107%	+$981K	0.02%	456
2024 Q3	$984K	Buy	+14,006	New	+$984K	0.01%	650